Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous intravenous nefopam for postoperative analgesia after decompressive laminectomy and fusion in multi-level spinal metastases
TCTR20220616001Phase 4Unknown
- Sponsor
- N/A
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nefopam in spinal metastases, postoperative pain, sponsored by N/A. Status: unknown.
02
Drugs
nefopam
03
Conditions
spinal metastasespostoperative pain
Beyond the preview
Go deeper on TCTR20220616001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220616001.